Vertex Pharmaceuticals Inc. buy BMO Capital Markets
Start price
07.11.23
/
50%
€357.80
Target price
07.11.24
€388.11
Performance (%)
21.48%
Price
17:53
€434.65
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 21.48%. This prediction currently runs until 07.11.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Vertex Pharmaceuticals Inc. | -0.679% | -0.679% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
Comments by BMO_Capital_Markets for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at BMO Capital Markets from $389.00 to $415.00. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by BMO_Capital_Markets for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€413.40
31.05.24
31.05.24
€459.80
31.05.25
31.05.25
5.14%
17:53
17:53
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€327.35
02.08.23
02.08.23
€355.55
02.08.24
02.08.24
35.94%
03.08.24
03.08.24